v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 4 $ 342,780 $ 52 $ (309,878) $ 32,958
Balance (in shares) at Dec. 31, 2024 38,194,442        
Increase (Decrease) in Stockholders' Equity          
Unrealized loss on marketable securities     (15)   (15)
Stock-based compensation   2,965     2,965
Restricted stock unit vesting   (387)     (387)
Restricted stock unit vesting (in shares) 95,958        
Exercise of stock options   91     91
Exercise of stock options (in shares) 22,112        
Net loss       (18,755) (18,755)
Balance at Mar. 31, 2025 $ 4 345,449 37 (328,633) 16,857
Balance (in Shares) at Mar. 31, 2025 38,312,512        
Balance at Dec. 31, 2025 $ 6 416,083 60 (362,579) 53,570
Balance (in shares) at Dec. 31, 2025 57,032,963        
Increase (Decrease) in Stockholders' Equity          
At-the-Market offering, net of issuance costs   5,855     5,855
At-the-Market offering, net of issuance costs (in shares) 1,451,439        
Unrealized loss on marketable securities     (100)   (100)
Stock-based compensation   2,851     2,851
Restricted stock unit vesting   (354)     (354)
Restricted stock unit vesting (in shares) 140,035        
Exercise of stock options   26     26
Exercise of stock options (in shares) 6,278        
Adjustment to carrying value of Series A Preferred Stock   35     35
Net loss       (20,691) (20,691)
Balance at Mar. 31, 2026 $ 6 $ 424,496 $ (40) $ (383,270) $ 41,192
Balance (in Shares) at Mar. 31, 2026 58,630,715